natgillin/translations-raw huggingface dataset:
• You can carry out the following injections yourself as long as your doctor has made you aware of the symptoms that may indicate allergy and of the possibly serious or life-threatening consequences that would need immediate treatment (see section 4 ‘Possible side effects').
• Naslednje injekcije si lahko dajete sami, pod pogojem, da vas je zdravnik seznanil z znaki, ki lahko kažejo na alergijo in o hudih, življenjsko nevarnih posledicah, ki zahtevajo takojšnjo zdravniško pomoč (glejte poglavje 4 'Možni neželeni učinki').
• Make sure that you collect all of your medicine from the vial.
• Prepričajte se, da ste iz viale povlekli celotno količino zdravila.
If you forget to use Cetrotide
Če ste pozabili uporabiti zdravilo Cetrotide
Allergic reactions - Warm, red skin, itching (often in your groin or armpits), red, itchy, raised areas (hives), runny nose, fast or uneven pulse, swelling of your tongue and throat, sneezing, wheezing or serious difficulty breathing, or dizziness.
• Vroča, pordela koža, srbenje (pogosto v dimljah ali pazduhah), rdeča, srbeča, dvignjena področja (izpuščaji), izcedek iz nosu, hiter ali neenakomeren srčni utrip, otekanje jezika in grla, kihanje, sopenje ali hude težave z dihanjem ali omotičnost.
The first administration of Cetrotide should be performed under the supervision of a physician and under conditions where treatment of possible allergic/pseudo-allergic reactions (including life-threatening anaphylaxis) is immediately available.
Prvo dajanje zdravila Cetrotide se mora izvesti pod nadzorom zdravnika in v pogojih, kjer je zdravljenje možnih alergijskih/psevdoalergijskih reakcij (vključno z življenjsko nevarno anafilaktično reakcijo) takoj na voljo.
• if you are pregnant or breast-feeding.
• če ste noseči ali dojite,
The injection site reactions may be minimised by rotating the injection sites, delaying injection at the same site and injecting the medicinal product in a slow rate to facilitate the progressive absorption of the medicinal product.
Reakcije na mestu injiciranja se lahko zmanjša, če se mesto injiciranja menjuje, s čimer se injiciranje na isto mesto časovno preloži, in če se zdravilo injicira počasi, da se omogoči postopno absorpcijo zdravila.
The starting day of Cetrotide is depending on the ovarian response, i.e. the number and size of growing follicles and/or the amount of circulating oestradiol.
Začetek dajanja zdravila Cetrotide je odvisen od odziva jajčnikov, tj. števila in velikosti rastočih foliklov in/ali količine estradiola v krvi.
6.6 Special precautions for disposal and other handling This medicinal product must be allowed to reach room temperature prior to injection.
6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Zdravilo mora pred injiciranjem doseči sobno temperaturo.
Special care should be taken in women with signs and symptoms of active allergic conditions or known history of allergic predisposition.
Posebna pozornost je potrebna pri ženskah z znaki in simptomi aktivnih alergijskih stanj ali s potrjeno alergijsko predispozicijo v anamnezi.
• two alcohol swabs.
• dve alkoholni blazinici.
• Do not inject a double dose to make up for a forgotten dose.
• Ne injicirajte si dvojnega odmerka, če ste pozabili uporabiti prejšnji odmerek.
Cetrorelix is contraindicated in patients with severe renal impairment (see section 4.3).
Cetroreliks je kontraindiciran pri bolnicah s hudo ledvično okvaro (glejte poglavje 4.3).
• Put the cap back on the needles so that they are safe to be thrown away.
• Na igle ponovno namestite zaporko, da jih lahko varno zavržete.
Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.
Preprečevanje prezgodnje ovulacije pri bolnicah v postopku nadzorovane ovarijske stimulacije, ki ji sledi odvzem oocitov in tehnike asistirane reprodukcije.
• To remove air bubbles, gently flick the syringe until all the air collects at the top - then slowly push the plunger in until the air bubbles are gone.
• Da odstranite mehurčke, s prsti nežno udarjajte po brizgi, da se vsi mehurčki zberejo na vrhu - nato počasi potiskajte bat, dokler vsi mehurčki ne izginejo.
In women undergoing ovarian stimulation the duration of action of cetrorelix is dose dependent.
Pri ženskah v postopku ovarijske stimulacije, je trajanje delovanja cetroreliksa odvisno od odmerka.
Elimination The total plasma clearance and the renal clearance are 1.2 mL x min x kg and 0.1 mL x min x kg respectively.
Izločanje Celotni plazemski in ledvični očistek sta 1,2 ml x min x kg oziroma 0,1 ml x min x kg
• if you are allergic to medicines similar to Cetrotide (any other peptide hormones).
• če ste alergični na zdravila, podobna zdravilu Cetrotide (druge peptidne hormone),
The following injections may be self-administered as long as the patient is made aware of the signs and symptoms that may indicate hypersensitivity, the consequences of such a reaction and the need for immediate medical intervention.
Nadaljnje injekcije si lahko bolnica daje sama, če je seznanjena z znaki in simptomi, ki lahko kažejo na preobčutljivostno reakcijo, posledicami takšne reakcije in potrebo po takojšnjem zdravniškem ukrepanju.
Mixing the powder and water in the vial
Mešanje praška in vode v viali
If you are not sure, talk to your doctor before using this medicine.
Če ste negotovi, se pred začetkom uporabe tega zdravila posvetujte z zdravnikom.
The mean terminal half-lives following intravenous and subcutaneous administration are about 12 h and 30 h, respectively, demonstrating the effect of absorption processes at the injection site.
Povprečen končni razpolovni čas po intravenski in subkutani uporabi je približno 12 ur oziroma 30 ur, kar dokazuje učinek procesa absorpcije na mestu injiciranja.
This medicine stops your body from releasing an egg from your ovary (ovulation) during your menstrual cycle.
To zdravilo prepreči, da bi vaše telo med menstrualnim ciklusom sprostilo jajčece iz jajčnika (ovulacija).
• empty your medicine into a sink and follow Step 6 below
• Zdravilo izpraznite v korito in sledite navodilom v 6. koraku spodaj.
• Your doctor must supervise your first injection.
• Dajanje prve injekcije se mora izvesti pod nadzorom vašega zdravnika.
Cases of allergic/pseudoallergic reactions, including life-threatening anaphylaxis with the first dose have been reported (see section 4.8).
Poročali so o primerih alergijskih/psevdoalergijskih reakcij, vključno z življenjsko nevarno anafilaktično reakcijo ob prvem odmerku (glejte poglavje 4.8).
Administration in the evening
Uporaba zvečer
Do not use Cetrotide
Ne uporabljajte zdravila Cetrotide
When your eggs are ready to be collected, another medicine will be given to you that will release them (ovulation induction).
Ko bodo vaša jajčeca pripravljena za odvzem, boste prejeli drugo zdravilo, ki bo jajčeca sprostilo (indukcija ovulacije).
During or after you receive these medicines, you may develop OHSS.
Med jemanjem teh zdravil ali po tem lahko pride do OHSS.
Adding the water from the pre-filled syringe to the powder in the vial
Dodajanje vode iz napolnjene brizge k prašku v viali
The contents of 1 vial (0.25 mg cetrorelix) are to be administered once daily, at 24 h intervals, either in the morning or in the evening.
Vsebino 1 viale (0,25 mg cetroreliksa) je treba injicirati enkrat na dan, v 24-urnih razmakih, bodisi zjutraj ali zvečer.
For possible signs to look out for and what to do if this happens see section 4 ‘Possible side effects'.
Za možne simptome, na katere morate biti pozorni, in za ukrepanje v teh primerih glejte poglavje 4 'Možni neželeni učinki'.
Cetrotide has no or negligible influence on the ability to drive and use machines.
Zdravilo Cetrotide nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
What you need to know before you use Cetrotide
Kaj morate vedeti, preden boste uporabili zdravilo Cetrotide
Due to this mode of action, cetrorelix controls the secretion of gonadotropins (LH and FSH).
Zaradi takega načina delovanja, cetroreliks uravnava izločanje gonadotropinov (LH in FSH).
INFORMATION IN BRAILLE cetrotide 0.25 mg
PODATKI V BRAILLOVI PISAVI cetrotide 0,25 mg
The entire contents of the vial should be withdrawn to ensure a delivery to the patient of a dose of at least 0.23 mg cetrorelix.
V brizgo je treba potegniti celotno vsebino viale, da zagotovite, da bolnica prejme najmanj 0,23 mg cetroreliksa.
Limited data from clinical follow-up studies in 316 newborns of women administered cetrorelix for infertility treatments suggest that cetrorelix does not increase the risk of congenital anomalies in the offsprings.
Omejeni podatki dopolnilnih kliničnih študij pri 316 novorojencih žensk, ki so se zaradi neplodnosti zdravile s cetroreliksom, kažejo, da cetroreliks ne povečuje tveganja prirojenih okvar pri potomcih.
Local reactions at the injection site (e.g. erythema, swelling and pruritus).
lokalne reakcije na mestu injiciranja (npr. eritem, oteklina in srbenje).
No teratogenic effects occurred when the medicinal product was administered during the sensitive phase of gestation.
Pri uporabi zdravila med občutljivo fazo gestacije se niso pojavili teratogeni učinki.
Merck Healthcare KGaA, Frankfurter Straße 250 D-64293 Darmstadt Germany
Merck Healthcare KGaA, Frankfurter Straße 250 D-64293 Darmstadt Nemčija
Driving and using machines Cetrotide is not expected to affect your ability to drive and use machines.
Vpliv na sposobnost upravljanja vozil in strojev Ne pričakuje se, da bi zdravilo Cetrotide vplivalo na vašo sposobnost vožnje in upravljanja strojev.
• If you are injecting every morning: Start your injections on day 5 or 6 of the treatment cycle.
• Če zdravilo injicirate vsako jutro: Začnite z injiciranjem na 5. ali 6. dan cikla zdravljenja.
- The OHSS may become severe with clearly enlarged ovaries, decreased urine production, weight gain, difficulty breathing or fluid in your stomach or chest.
• Sindrom OHSS lahko postane resen z vidno povečanimi jajčniki, zmanjšanim proizvajanjem urina, povečanjem telesne mase, oteženim dihanjem ali tekočino v trebuhu ali prsnem košu.
• Patients with severe renal impairment.
• Bolnice s hudo ledvično okvaro.
In animals as well as in humans, the antagonistic hormonal effects of cetrorelix were fully reversible after termination of treatment.
Po končanem zdravljenju so bili, tako pri živalih kot pri človeku, antagonistični hormonski učinki cetroreliksa popolnoma reverzibilni.
The subcutaneous administration of single doses (0.25 mg to 3 mg cetrorelix) and also daily dosing over 14 days show linear kinetics.
Subkutana uporaba enkratnih odmerkov (0,25 mg do 3 mg cetroreliksa) in tudi dnevno odmerjanje, daljše od 14 dni, kaže linearno kinetiko.
HOW TO MIX AND INJECT CETROTIDE
KAKO MEŠATI IN INJICIRATI ZDRAVILO CETROTIDE
What Cetrotide is and what it is used for
Kaj je zdravilo Cetrotide in za kaj ga uporabljamo
Cetrorelix showed no mutagenic or clastogenic potential in gene and chromosome mutation assays.
Cetroreliks v genskih in kromosomskih testih mutagenosti ni pokazal mutagenega ali klastogenega potenciala.
In females, cetrorelix delays the LH surge and consequently ovulation.
Pri ženskah cetroreliks odloži porast LH in posledično ovulacijo.
• Please carefully read and follow the instructions at the end of this leaflet called ‘How to mix and inject Cetrotide'.
• Pozorno preberite in upoštevajte navodila 'Kako mešati in injicirati zdravilo Cetrotide', ki se nahajajo na koncu teh navodil.
Studies in animals have indicated that cetrorelix exerts a dose related influence on fertility, reproductive performance and pregnancy.
Študije na živalih so pokazale, da je vpliv cetroreliksa na plodnost, sposobnost razmnoževanja in nosečnost odvisen od odmerka.
• Do not shake or you will create bubbles in your medicine.
• Ne tresite, saj bi s tem povzročili nastanek mehurčkov v zdravilu.
• When the syringe is empty, take out the grey needle slowly at the same angle.
• Ko je brizga prazna, počasi izvlecite sivo iglo pod istim kotom.
• Clean the skin at your chosen injection site with your second alcohol swab - use a circular motion.
• Na izbranem mestu injiciranja očistite kožo z drugo alkoholno blazinico - uporabljajte krožne gibe.
The most commonly reported adverse reactions are local injection site reactions such as erythema, swelling and pruritus that are usually transient in nature and mild in intensity.
Neželeni učinki, o katerih so najpogosteje poročali, so lokalne reakcije na mestu injiciranja, kot so eritem, oteklina in srbenje, ki so običajno prehodne in blage.
What Cetrotide is and what it is used for What you need to know before you use Cetrotide How to use Cetrotide
Kaj je zdravilo Cetrotide in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Cetrotide Kako uporabljati zdravilo Cetrotide Možni neželeni učinki
Cetrorelix competes with the binding of endogenous LHRH to these receptors.
Cetroreliks tekmuje z endogenim LHRH za te receptorje.
Piercing your skin
Prebadanje kože
Re-filling the syringe with the medicine from the vial
Ponovno polnjenje brizge z zdravilom iz viale
Using this medicine This medicine is only for injection just under the skin of your belly (subcutaneous).
To zdravilo je namenjeno samo dajanju v obliki injekcije tik pod kožo v trebuh (subkutano).
- Lower abdominal pain together with feeling sick (nausea) or being sick (vomiting) may be the symptoms of OHSS.
• Bolečina v spodnjem delu trebuha in občutek siljenja na bruhanje (slabost) ali bruhanje so lahko simptomi OHSS.
1 pre-filled syringe contains 1 ml of water for injections.
1 napolnjena injekcijska brizga vsebuje 1 ml vode za injekcije.
Marketing Authorisation Holder Merck Europe B.V., Gustav Mahlerplein 102, 1082 MA Amsterdam, The Netherlands
Imetnik dovoljenja za promet z zdravilom Merck Europe B.V., Gustav Mahlerplein 102, 1082 MA Amsterdam, Nizozemska
Manufacturer Merck Healthcare KGaA, Frankfurter Straße 250, D-64293 Darmstadt, Germany
Izdelovalec Merck Healthcare KGaA, Frankfurter Straße 250, D-64293 Darmstadt, Nemčija
• While carefully holding the syringe and vial, swirl gently to mix the powder and water together.
• Brizgo in vialo previdno držite ter ju nežno zavrtite, da se voda in prašek zmešata.
Mixing the powder and water to make up your medicine
Mešanje praška in vode za pripravo zdravila
Inject the contents of one vial (0.25 mg Cetrotide) once each day.
Injicirajte vsebino ene viale (0,25 mg zdravila Cetrotide), vsak dan enkrat.
• LHRH controls another hormone, called LH (‘luteinising hormone').
• LHRH nadzoruje drug hormon, imenovan LH (‘luteinizirajoči hormon').
Experience of using Cetrotide during more than one cycle is small.
Uporaba zdravila Cetrotide v več kot enem ciklusu Izkušenj z jemanjem zdravila Cetrotide v več kot enem ciklusu je malo.
No formal drug-drug interaction studies have been performed with cetrorelix.
Formalnih študij medsebojnega delovanja zdravil s cetroreliksom niso izvedli.
• This section tells you how to mix the powder and the sterile water (solvent) together and then how to inject your medicine.
• V tem poglavju boste našli navodila, kako zmešati prašek in sterilno vodo (vehikel) in kako injicirati zdravilo.
In vitro investigations have shown that interactions are unlikely with medicinal products that are metabolised by cytochrome P450 or glucuronised or conjugated in some other way.
Raziskave in vitro so pokazale, da so interakcije z zdravili, ki se presnavljajo s citokromom P450, glukuronidirajo ali konjugirajo na kakšen drug način, le malo verjetne.
Treatment with Cetrotide is not advised in women with severe allergic conditions.
Zdravljenje z zdravilom Cetrotide se odsvetuje ženskam s hudimi alergijskimi stanji.
Pre-filled syringe (Type I glass) with plunger stopper (siliconised bromobutyl rubber) and tip cap (polypropylene and styrene butadiene rubber).
Napolnjena injekcijska brizga (steklo tipa I) z batnim zamaškom (silikonizirana bromobutilna guma) in pokrovčkom (polipropilen in stiren butadien guma).
It is available in packs of 1 vial and 1 pre-filled syringe or 7 vials and 7 pre-filled syringes (not all pack sizes may be marketed).
Na voljo je v pakiranju z 1 vialo in 1 napolnjeno injekcijsko brizgo ali s 7 vialami in 7 napolnjenimi injekcijskimi brizgami (na trgu morda ni vseh navedenih pakiranj).
• If any medicine is left in the vial, pull out the yellow needle until the end of the needle is just inside the rubber stopper.
• Če v viali ostane nekaj zdravila, rumeno iglo izvlecite toliko, da konec igle komaj sega v gumijasti zamašek.
The unopened medicine may be stored in the original package at room temperature (not above 30°C) for up to three months.
Neodprto zdravilo lahko shranjujete v originalni ovojnini pri sobni temperaturi (do 30 °C) do tri mesece.
Method of administration Cetrotide is for subcutaneous injection into the lower abdominal wall.
Način uporabe Zdravilo Cetrotide je namenjeno za subkutano injiciranje v spodnji del trebušne stene.
• Put the cap back on the yellow needle.
• Zaporko namestite nazaj na rumeno iglo.
5 How to store Cetrotide Contents of the pack and other information How to mix and inject Cetrotide
Shranjevanje zdravila Cetrotide Vsebina pakiranja in dodatne informacije Kako mešati in injicirati zdravilo Cetrotide
If you notice any of the side effects above, stop using Cetrotide and contact your doctor immediately.
Če opazite katerega koli od zgoraj navedenih neželenih učinkov, prenehajte jemati zdravilo Cetrotide in nemudoma obvestite svojega zdravnika.
Treatment with Cetrotide should commence on day 5 of ovarian stimulation (approximately 96 to 108 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period until the evening prior to the day of ovulation induction.
Zdravljenje z zdravilom Cetrotide moramo začeti na 5. dan ovarijske stimulacije (približno 96 do 108 ur po začetku ovarijske stimulacije) z urinskimi ali rekombinantnimi gonadotropini in ga nadaljujemo ves čas zdravljenja z gonadotropini, vse do večera pred dnevom indukcije ovulacije.
• Wipe the rubber stopper and metal ring with your first alcohol swab.
• Gumijasti zamašek in kovinski obroček obrišite s prvo alkoholno blazinico.
Powder Mannitol
Prašek manitol
Treatment with Cetrotide should commence on day 5 or 6 of ovarian stimulation (approximately 96 to 120 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period including the day of ovulation induction.
Zdravljenje z zdravilom Cetrotide moramo začeti na 5. ali 6. dan ovarijske stimulacije (približno 96 do 120 ur po začetku ovarijske stimulacije) z urinskimi ali rekombinantnimi gonadotropini in ga nadaljujemo ves čas zdravljenja z gonadotropini, vključno z dnevom indukcije ovulacije.
• In the solvent: water for injections.
• V vehiklu: voda za injekcije.
Other medicines and Cetrotide Tell your doctor if you are using, have recently used or might use any other medicines.
Obvestite zdravnika, če uporabljate, ste pred kratkim uporabljali ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
Then, gently pull back the plunger, in order to draw the medicine from the vial into the syringe.
Nato bat brizge nežno povlecite nazaj, da povlečete zdravilo iz viale v brizgo.
LHRH binds to membrane receptors on pituitary cells.
LHRH se veže na membranske receptorje hipofiznih celic.
Inversely, severe OHSS remains uncommon.
Nasprotno pa se hud OHSS pojavi le občasno.
The reconstituted solution is without particles and clear.
Rekonstituirana raztopina ne vsebuje delcev in je bistra.
• If you are injecting every evening: Start your injections on day 5 of the treatment cycle.
• Če zdravilo injicirate zvečer: Začnite z injiciranjem 5. dan cikla zdravljenja.
• Gently pinch up the skin around where you are going to inject and hold this firmly with your other hand.
• Kožo okoli mesta injiciranja nežno stisnite in jo čvrsto držite z drugo roko.
• Slowly push in the plunger of the syringe to inject the water into the vial.
• Počasi potiskajte bat brizge, da vodo injicirate v vialo.
• one vial of powder
• eno vialo praška
In acute toxicity studies in rodents non-specific toxic symptoms were observed after intraperitoneal administration of cetrorelix doses more than 200 times higher than the pharmacologically effective dose after subcutaneous administration.
V študijah akutne toksičnosti z glodalci so opazili nespecifične toksične znake po intraperitonealni aplikaciji cetroreliksa v odmerkih, ki so bili 200-krat večji od farmakološko učinkovitega odmerka po subkutani uporabi.
No signs of medicinal product-related local irritation or incompatibility were noted in dogs after intravenous, intraarterial and paravenous injection when cetrorelix was administered in doses clearly above the intended clinical use in man.
Prav tako ni bilo znakov z zdravilom povezanega lokalnega draženja ali inkompatibilnosti pri psih, po intravenski, intraarterijski in paravenski injekciji cetroreliksa v odmerkih, ki so izrazito presegali namen klinične uporabe pri človeku.
Uncommonly, cases of hypersensitivity reactions including pseudo-allergic/anaphylactoid reactions have been reported.
Poročali so o občasnih primerih preobčutljivostnih reakcij, vključno s psevdoalergijskimi/anafilaktoidnimi reakcijami.
The solution should be used immediately after preparation.
Raztopino morate uporabiti takoj po pripravi.
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 0.25 mg
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT 0,25 mg
• Push the yellow needle through the centre of the rubber stopper of the vial.
• Rumeno iglo potisnite skozi sredino gumijastega zamaška viale.
Do not use if the solution contains particles or if the solution is not clear.
Ne uporabljajte raztopine, če vsebuje delce ali če ni bistra.
Paediatric population There is no relevant use of Cetrotide in the paediatric population.
Pediatrična populacija Zdravilo Cetrotide ni namenjeno za uporabo pri pediatrični populaciji.
Appearance of the powder: white lyophilisate Appearance of the solvent: clear and colourless solution The pH of the reconstituted solution is 4.0-6.0.
FARMACEVTSKA OBLIKA prašek in vehikel za raztopino za injiciranje Videz praška: bel liofilizat Videz vehikla: bistra in brezbarvna raztopina pH rekonstituirane raztopine je 4,0 do 6,0.
You will keep using this medicine up until and including the morning that your eggs are collected (ovulation induction).
Zdravilo boste uporabljali do in vključno z jutrom, ko bodo odvzeta vaša jajčeca (indukcija ovulacije).
The solvent is a clear and colourless solution in a pre-filled syringe.
Vehikel je bistra in brezbarvna raztopina v napolnjeni injekcijski brizgi.
1 vial and 1 pre-filled syringe or 7 vials and 7 pre-filled syringes.
1 viala in 1 napolnjena injekcijska brizga ali 7 vial in 7 napolnjenih injekcijskih brizg.
The white powder comes in a glass vial with a rubber stopper.
Bel prašek je na voljo v stekleni viali z gumijastim zamaškom.
Cetrorelix is a luteinising hormone releasing hormone (LHRH) antagonist.
Cetroreliks je antagonist luteinizirajoči hormon sproščajočega hormona (LHRH).
UNIQUE IDENTIFIER - 2D BARCODE 2D barcode carrying the unique identifier code 18.
EDINSTVENA OZNAKA - DVODIMENZIONALNA ČRTNA KODA Vsebuje dvodimenzionalno črtno kodo z edinstveno oznako.
You will keep using this medicine up until and including the evening before your eggs are collected (ovulation induction).
Zdravilo boste uporabljali do in vključno z večerom pred odvzemom jajčec (indukcija ovulacije).
Cetrotide belongs to a group of medicines called ‘anti-gonadotropin-releasing hormones'.
Zdravilo Cetrotide spada v skupino zdravil, ki se imenujejo 'antagonisti gonadotropin sproščajočega hormona'.
During or following ovarian stimulation an ovarian hyperstimulation syndrome can occur.
Sindrom ovarijske hiperstimulacije (OHSS, Ovarian Hyperstimulation Syndrome) Med ovarijsko stimulacijo ali po njej se lahko pojavi sindrom ovarijske hiperstimulacije.
• Slowly push the grey needle completely into your skin at an angle of about 45 to
• Sivo iglo počasi v celoti potisnite v kožo pod kotom okoli 45 do 90 stopinj - nato kožo spustite.
• Leave the syringe in the rubber stopper.
• Brizgo pustite v gumijastem zamašku.